Morgan Stanley
-
-
-
-
-
-
-
Morgan Stanley on Abbvie (ABBV) Buying Capstan: 'We view this acquisition as an incremental positive'
-
-
-
-
-
-
-
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $31.26 Per Share, $10.1 Billion
-
-
-
-
-
-
-
Morgan Stanley Reiterates Overweight Rating on Abbvie (ABBV) Following Healthcare Conference
-
-
-
-
-
-
-
Abbvie (ABBV) To Benefit from Imbruvica Patents Now Good Until 2032 - Morgan Stanley
-
-
-
-
-
-
-
UPDATE: Abbvie (ABBV) PT Lowered to $116 at Morgan Stanley on Lower Rinvoq Sales
-
-
-
-
-
-
-
Gilead invests $5 billion to deepen ties with biotech Galapagos
-
-
-
-
-
-
-
AbbVie to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
-
222,074 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

